Alex Roepers
Atlantic Investment Management
Alex Roepers Dentsply Sirona Inc stake
total: 129
Atlantic Investment Management XRAY trades
- Total transactions:
- 2
- New positions:
- 1
- Added:
- 1
- Held since:
- 2026 Q1
- Held for:
- 2 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Alex Roepers holds 2,203,000 Dentsply Sirona Inc (XRAY) shares with a market value of roughly $23.37M accounting for 12.18% of the overall portfolio. To date, the estimated cost basis is nearly $10.88 for "buy" trades. Atlantic Investment Management first purchased XRAY in 2026 Q1, initially acquiring 610,000 shares. Since the initial investment in Dentsply Sirona Inc (XRAY), Atlantic Investment Management has made 1 more transaction.
When did Alex Roepers buy Dentsply Sirona Inc (XRAY)?
Alex Roepers first invested in Dentsply Sirona Inc (XRAY) in 2026 Q1 at the reported quarter-end price of $11.60 per share.
What's the cost basis of Atlantic Investment Management's XRAY stake?
The estimated cost basis for Dentsply Sirona Inc (XRAY) stake is around $10.88 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $10.88
Alex Roepers's historical trades in Dentsply Sirona Inc
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
12.18%
|
2,203,000
|
$10.61
|
$23,373,830
|
+261.15% (+1,593,000)
|
+8.8%
|
|
2026 Q1
|
4.12%
|
610,000
|
$11.60
|
$7,076,000
|
new
|
+4.12%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.